0001209191-23-043408.txt : 20230726 0001209191-23-043408.hdr.sgml : 20230726 20230726161015 ACCESSION NUMBER: 0001209191-23-043408 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230725 FILED AS OF DATE: 20230726 DATE AS OF CHANGE: 20230726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Manning Anthony M. CENTRAL INDEX KEY: 0001716468 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40522 FILM NUMBER: 231113701 MAIL ADDRESS: STREET 1: C/O PALATIN TECHNOLOGIES, INC. STREET 2: 4B CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monte Rosa Therapeutics, Inc. CENTRAL INDEX KEY: 0001826457 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 321 HARRISON AVENUE STREET 2: SUITE 900 CITY: BOSTON STATE: MA ZIP: 02118 BUSINESS PHONE: 617-949-2643 MAIL ADDRESS: STREET 1: 321 HARRISON AVENUE STREET 2: SUITE 900 CITY: BOSTON STATE: MA ZIP: 02118 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-07-25 0 0001826457 Monte Rosa Therapeutics, Inc. GLUE 0001716468 Manning Anthony M. MONTE ROSA THERAPEUTICS, INC. 321 HARRISON AVENUE, SUITE 900 BOSTON MA 02210 1 0 0 0 0 Stock Option (Right to Buy) 6.70 2023-07-25 4 A 0 41000 0.00 A 2033-07-24 Common Stock 41000 41000 D This option shall vest and become exercisable in 36 substantially equal monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date. /s/ Ajim Tamboli, Attorney-in-Fact 2023-07-26